Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock Options (Tables)

Stock Options (Tables)

9 Months Ended

Aug. 31, 2012

Share Based Compensation Arrangement by Share Based Payment Award [Line Items]


	Three Months Ended						Nine Months Ended
	August 31, 2012			August 31, 2011			August 31, 2012			August 31, 2011
Weighted average values:
Expected dividends		0	%		0	%		0	%		0	%
Expected volatility		115.76	%		108.85	%		112.50	%		107.62	%
Risk free interest rate		.74	%		1.02	%		.90	%		1.21	%
Expected life		5.0 years			5.7 years			5.6 years			5.6 years


	Nine Months Ended
	August 31, 2012
Weighted average values:
Expected dividends		0	%
Expected volatility		107.03	%
Risk free interest rate		1.00	%
Expected life		6.4 years

Stock option activity for options


	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Outstanding at November 30, 2011		608,419		$	2.40		6.38	$	37,490

Granted		698,500			1.90			$	200,375
Exercised		(33,562	)		1.83			$	22,801
Expired/forfeited		(122,280	)		2.20			$	24,806

Outstanding at August 31, 2012		1,151,077		$	2.14		7.28	$	297,213

Exercisable at August 31, 2012		820,062		$	2.10		7.66	$	268,206


	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)		Aggregate Intrinsic Value
Outstanding at November 30, 2011		—			—		—		—

Granted		1,170,000		$	1.73
Exercised		—			—
Expired/forfeited		(30,000	)		1.72

Outstanding at August 31, 2012		1,140,000		$	1.73		7.84	$	499,800

Exercisable at August 31, 2012		—			—		—		—

Information of outstanding and exercisable option and its price and contractual life


	Outstanding						Exercisable
Range of Exercise Prices	Outstanding		Weighted Average Remaining Contractual Life (Years)		Weighted Average Exercise Price		Outstanding		Weighted Average Exercise Price
$0.42 to $1.00		15,000		2.41	$	.68		15,000	$	.68
$1.01 to $ 2.00		546,988		7.89	$	1.68		507,797	$	1.69
$2.01 to $ 3.00		548,500		7.30	$	2.54		256,676	$	2.80
$3.01 to $ 4.00		40,589		.60	$	3.34		40,589	$	3.34

		1,151,077		7.28	$	2.14		820,062	$	2.10

Summary of the non-vested shares


	Shares			Weighted Average Grant-Date Fair Value
Non-vested at November 30, 2011		353,277		$	1.94

Granted		698,500			1.55
Vested		(638,074	)		1.65
Forfeited		(82,688	)		1.63

Non-vested at August 31, 2012		331,015		$	1.76

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References + Details